# Advanced Radiotherapy Cuts Prostate Cancer Treatment from 20 Sessions to Five
Men with prostate cancer in England now have access to a faster treatment option through the NHS. Advanced radiotherapy reduces the typical course from 20 sessions spanning six to eight weeks down to just five sessions delivered over one to two weeks.
The treatment, called stereotactic body radiotherapy (SBRT), delivers highly focused radiation doses directly to tumors with precision imaging guidance. This concentrated approach allows clinicians to eliminate cancer cells more efficiently than conventional radiotherapy.
The NHS expansion addresses two critical patient needs: speed and convenience. Men no longer need to commit months of their lives to daily hospital visits. The compressed timeline reduces disruption to work, family responsibilities, and overall quality of life during treatment. Fewer sessions also mean lower cumulative radiation exposure to surrounding healthy tissue.
Research supports this accelerated approach. Studies demonstrate that SBRT for localized prostate cancer produces comparable cure rates to traditional radiotherapy while improving patient experience. The treatment works best for men with early-stage prostate cancer confined to the gland, making it unsuitable for all cases but beneficial for appropriate candidates.
Access through the NHS represents significant progress for British patients. Previously, this advanced technology remained largely available through private treatment or remained unavailable to many. The decision to offer SBRT reflects growing clinical confidence in the technique's safety and effectiveness.
Not every man with prostate cancer qualifies for this accelerated approach. Doctors will assess individual cases to determine suitability based on cancer stage, location, and other health factors. Men diagnosed with prostate cancer should discuss all available treatment options with their oncology team, including conventional radiotherapy, SBRT, surgery, and active monitoring.
This development underscores how advancing technology reshapes cancer care. Shorter treatment courses mean patients return to normal life faster while achieving the same therapeutic goals, transforming the